Better beta cell activator

Arena Pharmaceuticals Inc. says its small molecule 19AJ receptor agonists to treat Type II diabetes exploit a new mechanism of action to activate pancreatic islet beta cells to secrete insulin, without the risk

Read the full 335 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE